Live from the NIH registry
Studies recruiting near Cincinnati right now
Top 25 of 1,128 recruiting studies, sorted by proximity — each links to its official registry page
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
University of Cincinnati Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: American Society of Clinical Oncology
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Cincinnati Eye Institute — Blue Ash, Ohio (9.3 mi)
· Sponsor: Genentech, Inc.
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: Nationwide Children's Hospital
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1
Interventional 604 participants sought
The Christ Hospital — Cincinnati, Ohio (1.1 mi)
· Sponsor: Revolution Medicines, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Oncology Hematology Care Clinical Trials LLC — Cincinnati, Ohio (1.1 mi)
· Sponsor: Regeneron Pharmaceuticals
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
University of Cincinnati Medical Center ( Site 0156) — Cincinnati, Ohio (1.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
Phase 3
Interventional 117 participants sought
Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension — Cincinnati, Ohio (1.1 mi)
· Sponsor: Bayer
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Good Samaritan Hospital - Cincinnati — Cincinnati, Ohio (1.1 mi)
· Sponsor: SWOG Cancer Research Network
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
Acute Pancreatitis
Phase 1, Phase 2
Interventional 42 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: St. Jude Children's Research Hospital
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
Good Samaritan Hospital - Cincinnati — Cincinnati, Ohio (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
BE WELL With Migraine: Brain Education and WELLness With Migraine
Migraine
N/A
Interventional 286 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: Wake Forest University Health Sciences
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG
Phase 2
Interventional 60 participants sought
Cincinnati Children's Hospital — Cincinnati, Ohio (1.1 mi)
· Sponsor: Nationwide Children's Hospital
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Cincinnati, Ohio (1.1 mi)
· Sponsor: Sameek Roychowdhury
ELEVATE High-Risk PCI Pivotal Study
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
N/A
Interventional 290 participants sought
Mercy Health — Cincinnati, Ohio (1.1 mi)
· Sponsor: Magenta Medical Ltd.
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Local Institution - 0383 — Cincinnati, Ohio (1.1 mi)
· Sponsor: Bristol-Myers Squibb
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
Cardiomyopathies, Heart Failure
N/A
Interventional 300 participants sought
TriHealth Hatton Research Institute — Cincinnati, Ohio (1.1 mi)
· Sponsor: Zoll Medical Corporation
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma
Phase 2
Interventional 38 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: Nationwide Children's Hospital
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
Cytomegalovirus (CMV)
Phase 3
Interventional 80 participants sought
Cincinnati Children's Hospital Medical Center - PIN — Cincinnati, Ohio (1.1 mi)
· Sponsor: Takeda
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
Systemic Lupus Erythematosus of Childhood (Disorder)
N/A
Interventional 175 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: Michigan State University
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Oncology Hematology Care — Cincinnati, Ohio (1.1 mi)
· Sponsor: SCRI Development Innovations, LLC
Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents
Bipolar Disorder (BD), Bipolar Disorder NOS
N/A
Interventional 80 participants sought
University of Cincinnati College of Medicine — Cincinnati, Ohio (1.1 mi)
· Sponsor: University of California, Los Angeles
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Cincinnati, Ohio (1.1 mi)
· Sponsor: AstraZeneca
A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
Secondary Hyperparathyroidism, Chronic Kidney Disease
Phase 3
Interventional 56 participants sought
Cincinnati Childrens Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: Amgen
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Arthritis and Rheumatology of Southwest Ohio — Liberty Township, Ohio (19.0 mi)
· Sponsor: University of Alabama at Birmingham